文献速递术前评估与围术期医学疼痛医学

COVID-19 时代非甾体抗炎药的镇痛应用

NSAIDs for analgesia in the era of COVID-19.
PubMed 文献 · Reg Anesth Pain Med · 2020-06-03

本文综述了 COVID-19 大流行期间非甾体抗炎药(NSAIDs)用于镇痛的安全性争议。目前没有令人信服的数据表明 NSAIDs 会加重 COVID-19 症状严重程度或增加感染风险。对于无 COVID-19 可疑症状的疼痛患者,NSAIDs 仍应是可行的镇痛选择。

要点

  • 无证据表明 NSAIDs 加重 COVID-19 或增加感染风险
  • 无 COVID-19 可疑症状的疼痛患者可继续使用 NSAIDs 镇痛
  • COVID-19 可疑症状包括咳嗽、发热/寒战、乏力、肌痛、嗅觉丧失等

核心结论

  • 目前没有令人信服的数据表明 NSAIDs 会加重 COVID-19 症状严重程度或增加感染可能性。
  • 对于无 COVID-19 可疑症状的疼痛患者,NSAIDs 应继续作为可行的镇痛选择。

主要发现

  • 全球范围内 NSAIDs 广泛用于疼痛治疗,COVID-19 大流行引发对其安全性的关注。
  • 现有数据不支持 NSAIDs 加重 COVID-19 或增加感染风险的担忧。

临床怎么用

  • 对无 COVID-19 可疑症状(咳嗽、发热/寒战、乏力、肌痛、嗅觉丧失等)的疼痛患者,可继续使用 NSAIDs 镇痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one's likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Herzberg DL, Sukumaran HP, Viscusi E, et al. NSAIDs for analgesia in the era of COVID-19. Reg Anesth Pain Med. 2020. PMID: 32499385. doi:10.1136/rapm-2020-101584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。